Author:
Ye Wenjing,Gu Wen,Guo Xuejun,Yi Ping,Meng Yishuang,Han Fengfeng,Yu Lingwei,Chen Yi,Zhang Guorui,Wang Xueting
Funder
National Natural Science Foundation of China
Natural Science Foundation of Shanghai
Clinical Research Plan of SHDC
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,Biomedical Engineering,General Medicine,Biomaterials,Radiological and Ultrasound Technology
Reference25 articles.
1. Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, et al. Glossary of terms for CT of the lungs: recommendations of the nomenclature committee of the Fleischner Society. Radiology. 1996;200(2):327–31.
2. Tang ER, Schreiner AM, Pua BB. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS). J Thorac Dis. 2014;6(Suppl 5):S489–501.
3. Kim HK, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, et al. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Anticancer Res. 2014;34(2):707–14.
4. Golding B, Luu A, Jones R, Viloria-Petit AM. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC). Mol Cancer. 2018;17:52.
5. Terry SF. Obama’s precision medicine initiative. Genet Test Mol Biomarkers. 2015;19(3):113–4.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献